I am looking forward with great interest to this Report
In particular I am waiting to see
- Growth in installed base and the numbers
- Progress in market penetration in the USA, currently about 40% and targetting 80% by FY 2024
- Market penetration outside US and the New GE partnership agreement
- Revenue growth....targetting more than doubling today's revenue by 2024
- Upgrading of Trophon to Trophon 2
- New Infection products and projected commercialistion
- NAN becoming the GOTO for Infection Control
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$3.89 |
Change
0.020(0.52%) |
Mkt cap ! $1.181B | |||
| Open | High | Low | Value | Volume |
| $3.85 | $3.92 | $3.79 | $3.253M | 841.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 136 | $3.81 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.91 | 5150 | 2 |
View Market Depth
| Last trade - 16.10pm 12/09/2025 (20 minute delay) ? |
| NAN (ASX) Chart |